Theriva Liabilities And Stockholders Equity from 2010 to 2024

TOVX Stock  USD 1.18  0.01  0.84%   
Theriva Biologics Liabilities And Stockholders Equity yearly trend continues to be fairly stable with very little volatility. Liabilities And Stockholders Equity is likely to outpace its year average in 2024. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Theriva Biologics' total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
1993-03-31
Previous Quarter
42.4 M
Current Value
40.1 M
Quarterly Volatility
22.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Theriva Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theriva Biologics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 101.5 K, Total Revenue of 0.0 or Other Operating Expenses of 13.9 M, as well as many indicators such as Price To Sales Ratio of 241, Dividend Yield of 0.0 or PTB Ratio of 0.17. Theriva financial statements analysis is a perfect complement when working with Theriva Biologics Valuation or Volatility modules.
  
Check out the analysis of Theriva Biologics Correlation against competitors.
For more information on how to buy Theriva Stock please use our How to Invest in Theriva Biologics guide.

Latest Theriva Biologics' Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Theriva Biologics over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Theriva Biologics' Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theriva Biologics' overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Theriva Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean29,432,797
Geometric Mean20,624,683
Coefficient Of Variation78.59
Mean Deviation18,641,889
Median19,144,000
Standard Deviation23,130,830
Sample Variance535T
Range70.1M
R-Value0.78
Mean Square Error221.3T
R-Squared0.62
Significance0.0005
Slope4,059,145
Total Sum of Squares7490.5T

Theriva Liabilities And Stockholders Equity History

202458 M
202355.2 M
202271.9 M
202170.4 M
20208.4 M
201917.2 M
201830.1 M

About Theriva Biologics Financial Statements

Theriva Biologics investors use historical fundamental indicators, such as Theriva Biologics' Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theriva Biologics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity55.2 M58 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theriva Stock Analysis

When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.